SCHEMBL21368088

SCHEMBL21368088

CNCc1cn2ncccc2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
TP53 P04637 3/20 0.47
KLKB1 P03952 3/20 0.36
RAB9A P51151 3/20 0.35
CYP2A6 P11509 3/20 0.34
ALDH1A1 P00352 3/20 0.33
HPGD P15428 3/20 0.33
NPC1 O15118 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ERCC5 P28715 1/20 0.33
PDE4A P27815 2/20 0.33
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32
PDE4D Q08499 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2C19 P33261 1/20 0.32
HSD17B10 Q99714 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2066642 0.80 PDE4A (0.35) KLKB1RAB9AALDH1A1NPC1SMN1; SMN2
SCHEMBL2066942 0.77 CDK2 (0.35) KDM4ETP53RAB9AALDH1A1HPGD
SCHEMBL9934111 0.77 ERCC5 (0.35) KLKB1ERCC5PDE4APDE4BPDE4D
SCHEMBL876570 0.77 KLKB1 (0.33) KLKB1RAB9ANPC1SMN1; SMN2ERCC5
SCHEMBL30224182 0.76 KDM4E (0.36) KDM4ERAB9AALDH1A1HPGDNPC1
SCHEMBL21167757 0.76 DYRK1A (0.41) KDM4ETP53CYP2A6CYP3A4ADRB2
SCHEMBL9968611 0.76 PDE4A (0.33) KLKB1ERCC5PDE4ARBP4
SCHEMBL9569919 0.74 ERCC5 (0.34) KLKB1ALDH1A1SMN1; SMN2ERCC5PDE4A
SCHEMBL7969411 0.74 KLKB1 (0.34) KLKB1ERCC5PDE4ARBP4
SCHEMBL5148627 0.73 POLB (0.35) KDM4EKLKB1ALDH1A1HPGDERCC5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019178129-A1 SUBSTITUTED IMIDAZOPYRIDINES AS INHIBITORS OF PLASMA KALLIKREIN AND USES THEREOF SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2019-09-19 WO disclosed